Section 31A-48-102 - DefinitionsAs used in this chapter:
(1)(a) "Drug" means a substance that is:(i)(A) intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans; and(B) recognized in or in a supplement to the official United States Pharmacopoeia, the Homeopathic Pharmacopoeia of the United States, or the official National Formulary;(ii) required by an applicable federal or state law or rule to be dispensed by prescription only;(iii) restricted to administration by practitioners only;(iv) a substance other than food intended to affect the structure or a function of the human body; or(v) intended for use as a component of a substance described in Subsection (1)(a)(i), (ii), (iii), or (iv).(b) "Drug" does not include a dietary supplement.(2) "Insurer" means the same as that term is defined in Section 31A-22-634.(3) "Manufacturer" means a person that is engaged in the manufacturing of a drug that is available for purchase by residents of the state.(4) "Rebate" means the same as that term is defined in Section 31A-46-102.(5) "Wholesale acquisition cost" means the same as that term is defined in 42 U.S.C. Sec. 1395w-3a.Amended by Chapter 198, 2022 General Session ,§ 31, eff. 5/4/2022.Added by Chapter 198, 2020 General Session ,§ 12, eff. 5/12/2020.Technically renumbered to avoid duplication of section number also enacted in HB402, Chapter 141.